Ulinastatin Ulinastatin is an inhibitor of serine protease and urinary trypsin with anti-inflammatory activity and is used in studies related to pancreatitis, sepsis and septic shock.
Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
|Related Serine/Threonine Protease Products|
PCSK9-IN-19 is a PCSK9 inhibitor.
Irucalantide is kallikrein inhibitor.
PCSK9-IN-14 is a potent PCSK9 inhibitor.
PKSI-527 is a new, highly selective plasma kallikrein inhibitor.
PCSK9-IN-18 is a potent PCSK9 inhibitor with a KD value of <200 nM.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.